Q2 FY2026 EarningsQ2 FY26 performance beat consensus, with revenue reaching $23.0M vs. $22.0M expected (+4.64% variance). Net income turned positive at $1.2M, supported by a 73% sequential revenue surge and the first full quarter of the amended Green Thumb licensing agreement. However, management declined to provide Q3 guidance due to looming regulatory uncertainty regarding federal hemp-derived THC laws effective November 2024.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: RYTHM(RYM) the Revenue is 23.02 M (+1027%);the EBIT is 1.936 M (+128.5%);the EPS is 0.0893 (+102.4%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B1027.38%
----
----
EBIT
0.00B128.48%
----
----
EPS
0.0893102.39%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf